Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 11 2
CoronaVac Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021 4 1
N-acetylcysteine Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Mar/06/2021 2 1
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Verteporfin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020 2 0
MVC-COV1901 Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020 2 0
Excel (.xslx) CSV (.csv)